4.7 Article

Colorimetric determination of sarcosine in urine samples of prostatic carcinoma by mimic enzyme palladium nanoparticles

Journal

ANALYTICA CHIMICA ACTA
Volume 825, Issue -, Pages 63-68

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.aca.2014.03.040

Keywords

Palladium nanoparticles; Mimic enzyme; Sarcosine; Prostatic carcinoma

Funding

  1. National Natural Science Foundation of China [21105012, 21205015, 91022025, 21375017]
  2. National Science Foundation of Fujian Province [2011J01028]
  3. Fujian University Outstanding Youth Scientific Research [JA11105, JA10295]
  4. National Science Foundation for Distinguished Young Scholars of Fujian Province [2013J06003]
  5. Fujian Science and Technology [2013Y0045]
  6. Youth Foundation of Fujian Health Department [2010126]
  7. Foundation of Medical Innovation of Fujian Health Department [2011-CX-22]
  8. Foundation of Fuzhou Science and Technology Bureau [2012-S-148]

Ask authors/readers for more resources

The proposed palladium nanoparticles (Pd NPs), which with the catalytic activity similar to the horseradish peroxidase (HRP) mimic enzyme, can effectively catalyze the H2O2-mediated oxidation of 3,3 ',5,5 '-tetramethylbenzidine sulfate (TMB) accompanied with a color change from colorless to blue in solution. And as a result, the sensitive detection of sarcosine can be realized by the naked eye observation and ultraviolet spectrophotometry, using Pd NPs as catalyst and TMB as the substrate of the simulation enzyme catalytic reaction. Under the optimal condition, the catalytic system of Pd NPs mimic enzyme can be used for the detection of sarcosine. It has been found that the color change could be clearly observed with the naked eyes, and the absorbance intensity at 653 nm showed a fine linear fitting with the concentration of sarcosine in the range from 0.01 mu M to 50 mu M, and the detection limit (3 sigma/S) for sarcosine was calculated to be 5.0 nM. In order to evaluate the feasibility and reliability, the method was also used for analyzing concentrations of sarcosine in human urine samples from diagnosed prostate cancer patients and healthy donors. It is expected to provide a convenient and efficient method for indirect evaluation for the diagnosis of prostatic carcinoma (PCa). (C) 2014 Elsevier B. V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available